Neill A. Giese

Statistics

Publications

Citations

5.6K

H-Index

Active since

1981

Affiliations

Millennium Engineering and Integration (United States)(Current)

Kyowa Kirin (Japan)

Dana-Farber Cancer Institute

The Ohio State University

Howard Hughes Medical Institute

Neill A. Giese is an author at Millennium Engineering and Integration (United States) specializing in signal transduction, life sciences, and cell signaling.

Publications per year

1981–2011

Publications

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

Brian J. Lannutti, Sarah Meadows, Sarah E. M. Herman et al. · Blood · 2010 · 718 citations · Full text

Medicine, Oncology, Pharmacology +11

Co-localization of NG2 proteoglycan and PDGF ?-receptor on O2A progenitor cells in the developing rat brain

Akiko Nishiyama, Xiaohong Lin, Neill A. Giese et al. · Journal of Neuroscience Research · 1996 · 631 citations

Medicine, Neurobiology, Neuroscience +14

The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

Julia Hoellenriegel, Sarah Meadows, Mariela Sivina et al. · Blood · 2011 · 548 citations · Full text

Life Sciences, Cancer Biology, Oncology +15

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E. M. Herman, Amber Gordon, Amy J. Wagner et al. · Blood · 2010 · 541 citations · Full text

Life Sciences, Oncology, Pharmacology +16

Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.

Nathalie A. Lokker, Carol M. Sullivan, Stanley J. Hollenbach et al. · PubMed · 2002 · 436 citations

Medicine, Cell Biology, Oncology +17

1–5 of 33